Intuitive Surgical Stock at Support Zone – Bargain or Trap?
Intuitive Surgical (ISRG) stock should be on your watchlist. Here is why – it is currently trading in the support zone ($429.14 – $474.32), levels from which it has bounced meaningfully before. Since it first started trading, Intuitive Surgical stock received buying interest at this level 5 times and subsequently went on to generate 22.3% in average peak returns.
| Peak Return | Days to Peak Return | |
|---|---|---|
| 6/24/2024 | 7.5% | 28 |
| 7/30/2024 | 14.2% | 44 |
| 10/7/2024 | 29.5% | 107 |
| 4/7/2025 | 22.1% | 37 |
| 10/10/2025 | 38.0% | 88 |
Yet, a support zone alone isn’t enough; rebounds are more likely when fundamentals, sentiment, and market conditions line up. How does that look for ISRG?
Rebound likely. Strong fundamentals, market tailwinds.
Intuitive Surgical’s Q1 2026 beat revenue and EPS expectations, with 23% revenue and 17% procedure growth, prompting raised 2026 guidance. A new $5B buyback supports value. Analyst consensus “Buy” rating points to a $580 median target, suggesting substantial upside from current pricing near its 52-week low. Expanding robotic surgery market, driven by AI integration and demand for minimally invasive procedures, provides a sustained tailwind against competitive pressures and minor regional headwinds.
- How ISRG Just Secured The U.S. Market
- Tired of AI and Oil? Buy the Robot.
- Better Value & Growth: PODD Leads Intuitive Surgical Stock
- Intuitive Surgical Stock Near Crucial Support – Buy Signal?
- Better Value & Growth: PODD Leads Intuitive Surgical Stock
- Stronger Bet Than Intuitive Surgical Stock: PODD Delivers More
How Do ISRG Financials Look Right Now?
- Revenue Growth: 21.4% LTM and 18.1% last 3-year average.
- Cash Generation: Nearly 26.8% free cash flow margin and 30.5% operating margin LTM.
- Recent Revenue Shocks: The minimum annual revenue growth in the last 3 years for ISRG was 13.8%.
- Valuation: ISRG stock trades at a PE multiple of 53.8
| ISRG | S&P Median | |
|---|---|---|
| Sector | Health Care | – |
| Industry | Health Care Equipment | – |
| PE Ratio | 53.8 | 24.0 |
|
|
||
| LTM* Revenue Growth | 21.4% | 7.2% |
| 3Y Average Annual Revenue Growth | 18.1% | 5.6% |
| Min Annual Revenue Growth Last 3Y | 13.8% | 0.8% |
|
|
||
| LTM* Operating Margin | 30.5% | 18.4% |
| 3Y Average Operating Margin | 28.0% | 18.3% |
| LTM* Free Cash Flow Margin | 26.8% | 14.5% |
*LTM: Last Twelve Months | For more details on ISRG fundamentals, read Buy or Sell ISRG Stock.
And What If The Support Breaks?
ISRG isn’t immune to big drops. It fell 82% during the Dot-Com Bubble and 76% in the Global Financial Crisis. The Inflation Shock saw nearly a 50% dip, and even the Covid sell-off wasn’t mild at 40%. The smaller 2018 correction still knocked it down 24%. So, no matter how strong a stock looks, sharp sell-offs can still hit hard.
But the risk is not limited to major market crashes. Stocks fall even when markets are in good shape – think events like earnings, business updates, outlook changes. Read ISRG Dip Buyer Analyses to see how the stock has recovered from sharp dips in the past.
Still not sure about ISRG stock? Consider the portfolio approach.
The Right Way To Invest Is Through Portfolios
Individual stocks can soar or tank, but one thing matters: staying invested. The right portfolio can help you stay invested, capture upside, and mitigate the downside associated with any individual stock.
Beating the market consistently is hard, but the Trefis High Quality (HQ) Portfolio makes it look achievable. By selecting 30 high-conviction stocks, the HQ strategy has historically outpaced the S&P 500, S&P Mid-cap, and Russell 2000. See how this curated selection delivers superior risk-adjusted returns in our detailed performance factsheet.